source
- STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policyThe Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling marijuana.STAT · 4mo ago↗ source
- Post-Hoc Live: MAHA, the new Trump CDC pick and RFK's vaccine agendaMAHA’s sway over HHS could face a fresh test now that President Trump has a new pick for CDC director: Erica Schwartz, a former deputy surgeon general. The position has been empty ...Endpoints · 4mo ago↗ source
- Novartis' radioligand therapy Lutathera could soon face generic competitionThe radioligand field is on the cusp of a major competitive moment, as a rival looks to bring the first generic to a market that’s been dominated by Novartis. Radioligand therapy aims to bring the ...